| A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies (NCT05032040) | Xencor, Inc. | 2022-07-21 |
| A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors (NCT05366478) | Suzhou BlueHorse Therapeutics Co., Ltd. | 2022-05-30 |
| Gynecological Sentinel Lymph Nodes CEUS (NCT05105087) | Thomas Jefferson University | 2022-04-28 |
| PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer (NCT05311566) | Lei Li | 2022-03-27 |
| Clinical Study of Indocyanine Green Displaying Pelvic Nerve in Radical Operation of Cervical Cancer (NCT05087264) | Fifth Affiliated Hospital, Sun Yat-Sen University | 2022-03-10 |
| Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study (NCT05180851) | Shanghai Fengxian District Central Hospital | 2021-11-30 |
| Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer (NCT05139368) | University of Utah | 2021-11-11 |
| Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia (NCT04411849) | Ohio State University Comprehensive Cancer Center | 2021-08-27 |
| Clinical Validation of Molecular Triage in HR-HPV Positive Women (NCT05193669) | Hiantis Srl | 2021-04-14 |
| Linguistically-Tailored Mobile Intervention for the Improvement of Follow Up for Abnormal Pap Test Results (NCT04821297) | Thomas Jefferson University | 2021-02-18 |
| Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy (NCT04713618) | Ohio State University Comprehensive Cancer Center | 2021-01-30 |
| Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer (NCT04567771) | Mayo Clinic | 2020-12-04 |
| Pembrolizumab and Olaparib in Cervical Cancer Patients (NCT04483544) | Baptist Health South Florida | 2020-12-03 |
| Support Program for Adoption of Cancer Screening Interventions at a Rural Community-Based Organization (NCT04208724) | Fred Hutchinson Cancer Center | 2020-11-18 |
| I Vaccinate: Testing Multi-Level Interventions to Improve HPV Vaccination (NCT04452526) | Ohio State University Comprehensive Cancer Center | 2020-10-21 |
| Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers (NCT04459273) | Jonsson Comprehensive Cancer Center | 2020-08-27 |
| Cervical Cytology - Do SMS Reminders Increase Participation in the Cervical Screening Programme? (NCT03975127) | NHS Greater Glasgow and Clyde | 2019-12-01 |
| A Study of LY3435151 in Participants With Solid Tumors (NCT04099277) | Eli Lilly and Company | 2019-10-28 |
| Study of Tumor Infiltrating Lymphocytes Following CCRT in the Treatment of Patients With Cervical Carcinoma (NCT04443296) | Sun Yat-sen University | 2019-10-12 |
| A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors (NCT03849469) | Xencor, Inc. | 2019-05-29 |
| A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) (NCT03752398) | Xencor, Inc. | 2019-05-01 |
| Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers (NCT03345784) | National Cancer Institute (NCI) | 2018-05-29 |
| Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors (NCT03372720) | Ohio State University Comprehensive Cancer Center | 2018-05-11 |
| Fractional CO2 Laser Therapy for Survivors of Breast Malignancies (NCT03307044) | Ohio State University Comprehensive Cancer Center | 2017-11-16 |
| Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma (NCT03220009) | National Cancer Institute (NCI) | 2017-11-03 |
| Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma (NCT03108495) | Iovance Biotherapeutics, Inc. | 2017-06-22 |
| Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer (NCT03180294) | NRG Oncology | 2017-05-31 |
| Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma (NCT03086681) | Yong Zhang,MD | 2017-04-20 |
| Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors (NCT02835833) | University of Alabama at Birmingham | 2016-06-09 |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) (NCT02628067) | Merck Sharp & Dohme LLC | 2015-12-18 |
| Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) (NCT02584478) | Advenchen Laboratories, LLC | 2015-12-01 |
| HPV Self-Test Intervention in Ohio Appalachia (NCT02460237) | Ohio State University Comprehensive Cancer Center | 2015-11-01 |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (NCT02465060) | National Cancer Institute (NCI) | 2015-08-17 |
| HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Cervical Carcinoma (NCT02523365) | Fuda Cancer Hospital, Guangzhou | 2015-05-01 |
| Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies (NCT02578888) | Albert Einstein College of Medicine | 2015-04-01 |
| Can Text Reminders Improve Uptake of Cervical Screening? (NCT02363088) | Sarah Huf | 2015-02-01 |
| Prevention and Early Detection of Cervical Cancer Through Self-Administered Screening (NCT04927650) | University of California, San Francisco | 2015-01-08 |
| CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers (NCT02355262) | OHSU Knight Cancer Institute | 2014-07-01 |
| Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies (NCT02025985) | Karyopharm Therapeutics Inc | 2014-04-09 |
| Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening (NCT01550783) | University of Washington | 2012-03-01 |
| Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical Carcinoma (NCT01554410) | University of California, San Diego | 2010-08-01 |
| Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls (NCT00867464) | National Cancer Institute (NCI) | 2009-03-30 |
| Cervical Cancer Screening Intervention Among Korean American Women (NCT02594826) | Fox Chase Cancer Center | 2009-02-01 |
| Ixabepilone to Treat Cervical Cancer (NCT00924066) | National Cancer Institute (NCI) | 2008-11-01 |
| Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer (NCT00791635) | M.D. Anderson Cancer Center | 2008-07-11 |
| Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia (NCT00081263) | Gynecologic Oncology Group | 2005-06-01 |
| Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma (NCT00595725) | Memorial Sloan Kettering Cancer Center | 2003-02-01 |
| Prognostic Value of Protein IMP3 Expression in Cervical Cancer (NCT05151159) | University of Mostar | 2003-01-01 |
| Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance (NCT00026663) | National Cancer Institute (NCI) | 2000-08-09 |